New lupus drug enters human testing – hope for patients?
Disease control
Not yet recruiting
This early-stage trial tests a new drug called IASO-782 in 20 adults with systemic lupus erythematosus (SLE). The main goal is to see if the drug is safe and tolerable. Participants will receive either the drug or a placebo, and researchers will monitor for side effects. This stu…
Phase: PHASE1 • Sponsor: Shanghai IASO Biotechnology Co., Ltd • Aim: Disease control
Last updated May 01, 2026 15:59 UTC